CLUSTER filed Jul 1, 2026 at 21:30 ET
{ "summary": "A massive insider selling cluster at Oruka Therapeutics: director/10% owner Fairmount Funds Management LLC sold 3.55M shares for $300M at $84.43, and the COO sold 2.2K shares for $210K. The Fairmount sale alone represents ~5.3% of ORKA's $5.7B market cap, a highly material disposition. The COO's sale is trivial by comparison. The cluster is overwhelmingly driven by a single large holder monetizing a converted derivative position, not by C-suite bearish conviction.", "sentiment